Compare · AMEH vs NUKK
AMEH vs NUKK
Side-by-side comparison of Apollo Medical Holdings Inc. (AMEH) and Nukkleus Inc. (NUKK): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both AMEH and NUKK operate in Professional Services (Consumer Discretionary), so they compete in similar markets.
- AMEH carries a market cap of $2.62B.
- AMEH has more recent analyst coverage (9 ratings vs 0 for NUKK).
- Company
- Apollo Medical Holdings Inc.
- Nukkleus Inc.
- Price
- $40.83-2.20%
- $2.06+8.14%
- Market cap
- $2.62B
- -
- 1M return
- -
- -39.32%
- 1Y return
- -
- -84.39%
- Industry
- Professional Services
- Professional Services
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2020
- News (4w)
- 0
- 0
- Recent ratings
- 9
- 0
Apollo Medical Holdings Inc.
Apollo Medical Holdings, Inc., a physician-centric technology-powered healthcare management company, provides medical care services. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The company's physician network consists of primary care physicians, specialist physicians, and hospitalists. It serves patients, primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization plans; and non-insured patients in California. The company was founded in 1994 and is headquartered in Alhambra, California.
Latest AMEH
- Apollo Medical Holdings Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits
- Apollo Medical Hlgs Q4 2023 GAAP EPS $0.26 Beats $0.15 Estimate, Sales $353.04M Beat $340.61M Estimate
- Apollo Medical Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Apollo Medical Hlgs's Earnings Outlook
- Jefferies Initiates Coverage On Apollo Medical Hlgs with Buy Rating, Announces Price Target of $50
- Apollo Medical Holdings Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits
- Apollo shares are trading higher after B of A Securities upgraded the stock from Neutral to Buy and raised its price target from $44 to $55.
- B of A Securities Upgrades Apollo Medical Hlgs to Buy, Raises Price Target to $55
- Apollo Medical upgraded by BofA Securities with a new price target
- Apollo Medical Holdings Announced That It Will Formally Change Its Name From Apollo Medical Holdings, Inc. To Astrana Health, Inc. And Will Begin Trading Under The Ticker Symbol "ASTH", Both Effective February 26, 2024
Latest NUKK
- Nukkleus Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Regulation FD Disclosure, Financial Statements and Exhibits
- SEC Form EFFECT filed by Nukkleus Inc.
- SEC Form 424B3 filed by Nukkleus Inc.
- Nukkleus Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
- SEC Form S-1 filed by Nukkleus Inc.
- Nukkleus Inc. Announces Corporate Rebranding: Changes Name to T3 Defense Inc. and Ticker Symbol to DFNS
- Nukkleus Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Financial Statements and Exhibits
- Nukkleus Subsidiary Rimon Wins Multi-Year Defense Contracts to Build Iron Dome Components
- Nukkleus Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- CEO Shalom Menachem exercised 200,000 in-the-money units of Common Stock $0.0001 par value per share at a strike of $1.50, increasing direct ownership by 6% to 3,442,010 units (SEC Form 4)